Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors

Histone deacetylases (HDACs) have emerged as important targets for cancer treatment. HDAC-inhibitors (HDACis) are well tolerated in patients and have been approved for the treatment of patients with cutaneous T-cell lymphoma (CTCL). To improve the clinical benefit of HDACis in solid tumors, combinat...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Kortenhorst, Madeleine SQ, Wissing, Michel D, Rodriguez, Ronald, Kachhap, Sushant K, Jans, Judith JM, Van der Groep, Petra, Verheul, Henk MW, Gupta, Anuj, Aiyetan, Paul O, van der Wall, Elsken, Carducci, Michael A, Van Diest, Paul J, Marchionni, Luigi
Natura: Artigo
Lingua:Inglês
Pubblicazione: Landes Bioscience 2013
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3883768/
https://ncbi.nlm.nih.gov/pubmed/23880963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/epi.25574
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi